Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of Diamyd (GAD-alum) plus vitamin D plus ibuprofen in recent-onset type 1 diabetes in children and adolescents
2012-003251-11Phase 2Completed
- Sponsor
- Linköping University
- Start
- Jul 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Diamyd in diabetes mellitus type 1 (T1D), sponsored by Linköping University. Primary endpoints: Th2 deviation of cell-mediated immune response, Safety and 1 more. Started Jul 2012; status: completed.
02
Drugs
Diamyd
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2012-003251-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003251-11.